Join us at EBF, a key event focused on bioanalytical method development, regulatory guidance and scientific innovation supporting biomarker programmes. Our teams work across bioanalysis and biomarker-related studies supporting drug development through clinical and preclinical programmes. We will be available to discuss analytical requirements, study considerations and other areas connected to regulated scientific support.
Explore our capabilities:
Attending from Synexa will be:
- Nicola Hickson, Business Development Director – LinkedIn
To request a meeting with Synexa at the event, email us at contactus@synexagroup.com.
